← Eichor
Study identifier: NCT06740799 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Assessment of Quizartinib Pharmacokinetic in Subjects With Severe Hepatic Impairment

Condition: Hepatic Impairment  ·  Sponsor: Daiichi Sankyo

PhasePhase 1
Planned participants12
Who can joinAll sexes, 18 Years to 75 Years
Healthy volunteersYes

About this study

This study will evaluate and compare the PK in subjects with severe HI to that of matched healthy control subjects with normal hepatic function.

This description comes directly from the study's public registry record.

Talk to the study team

Daiichi Sankyo Contact for Clinical Trial Information  ·  908-992-6400  ·  CTRinfo_us@daiichisankyo.com

Always discuss trial participation with your own doctor first.

Locations (3)

Clinical Pharmacology of Miami, LLCMiami, Florida, United StatesRecruiting
Advanced PharmaMiami, Florida, United StatesRecruiting
GCP ResearchSt. Petersburg, Florida, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06740799